EPN 0.00% 2.4¢ epsilon healthcare limited

Ann: Launch of Australian and International Medicines Supply, page-32

  1. 2,997 Posts.
    lightbulb Created with Sketch. 1052
    I think you have it down pat. THC will this year see Medicinal Cannabis revenue for the first time. When announcements have come, especially around licences, there have been little runs but then a re-trace. It is hard to know exactly how much revenue there will be going forward, when this happens, SP will move.

    With legislation changes, I hope they don't change any legislation or licences/permits that are needed in Australia as THC now have the full sweet of them and I hope that any new players to the scene would have to wait similar time frames and jump through the same hoops - but with anything, those who come later generally have an easier path but then have to battle companies who have a foot hold in markets - THC will be one with the first footholds. There might be a legislation change around the use of CBD in medicines and if it goes further, it may be allowed in over the counter pharma products. I don't think it will quite go as far as Canada yet and allow it in edibles - this may be a few years away, IMO. It seems AGH might be slightly ahead in the Aussie market, but are looking at different export markets and their revenue vs costs are no where near as close as THC's, IMO. CAN similar, they do not have a client base yet, but their products will be on the market in weeks as well. CAN's overheads seems large and they do not hold all of their own permits, they have a partnership with IDT who produces their finished products.

    No one has any idea what the prices for each of these products will be for customers. There are also questions about access and distribution and patients getting the products once prescriptions are given. I look forward to the parliamentary inquiry that is winding up in weeks that is looking at legislation and patient access etc. THC have been spruiking that they will have the highest quality and the most affordable cost to patients.

    One thing THC have over the others is the ability to grow, refine, produce and then sell their products within their vertically integrated company while the others don't. THC also have all of the required permits and licences to import/export raw ingredients and materials at the required standards - no other company holds all of these themselves in Australia and can produce the products at such a high standard by themselves. The only licence they are awaiting allows them to import into Canada to sale to Medicinal Cannabis patients. THC also have two established revenue streams which is keeping the bottom line going while they bring things online - while the others are burning cash each quarter.

    Well placed, IMO. I too am looking to add at lower prices to top up when i can afford it.
 
watchlist Created with Sketch. Add EPN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.